GelMEDIX >> logo
GelMEDIX >> logo

GelMEDIX >>

gelmedix.com
gelmedix.com • HQ: Newton, United States • Venture - Series Unknown 2025 • 51-200 employees • Founded 2020 • Startup
HQ: Newton, United States • Venture - Series Unknown 2025 • 51-200 employees • Founded 2020 • Startup
Actively hiring
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$3M
9 rounds on record
Latest round
$747k
Venture round · Oct 2025 · 12 mo ago
Team
51-200
employees, estimated range
Backers
2
Beacon Angels, Boston Harbor Angels
The money's age
Due for its next round
12 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 1, 2025 Raised a round Venture round $747k · SEC Form D Oct 1, 2025 Raised a round Venture round $747k · SEC Form D Oct 1, 2025 Raised a round Venture round $747k · SEC Form D Oct 1, 2025 Raised a round Venture round $747k · SEC Form D Jan 24, 2025 Took on debt financing $1M · SEC Form D Mar 11, 2024 Took on debt financing $1.9M · SEC Form D Jun 4, 2020 Took on debt financing $6.4M · SEC Form D Jun 4, 2020 Took on debt financing $6.4M · SEC Form D Jun 4, 2020 Took on debt financing $6.4M · SEC Form D 2020 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Oct 2025 $747k — SEC Form D
Venture round Oct 2025 $747k — SEC Form D
Venture round Oct 2025 $747k — SEC Form D
Venture round Oct 2025 $747k — SEC Form D
Debt Financing Jan 2025 $1M — SEC Form D
Debt Financing Mar 2024 $1.9M — SEC Form D
Debt Financing Jun 2020 $6.4M — SEC Form D
Debt Financing Jun 2020 $6.4M — SEC Form D
Debt Financing Jun 2020 $6.4M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity GelMEDIX, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Jeffrey BehrensExecutive Officer, DirectorSEC Form D
Arthur DriscollExecutive Officer, DirectorSEC Form D
Max CotlerExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Beacon Angels fund Boston Harbor Angels fund

People

Jeffrey Behrens
Executive Officer, Director
SEC Form D
Arthur Driscoll
Executive Officer, Director
SEC Form D
Max Cotler
Executive Officer, Director
SEC Form D
Reza Dana
Director
SEC Form D
Nasim Annabi
Director
SEC Form D
Michael Cima
Director
SEC Form D
Parinaz Motamedy
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Newton United States
HQ
Cambridge United States
Regional office
GelMEDIX, Inc.
238 Main St, Fifth Floor, Cambridge, MA 02142
company site

Financials

Total raised
$25.2M
Latest round
Venture - Series Unknown
Funding rounds
9
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $747k Details
Venture - Series Unknown 2025 $747k Details
Venture - Series Unknown 2025 $747k Details
Venture - Series Unknown 2025 $747k Details
Debt Financing 2025 $1M Details
Debt Financing 2024 $1.9M Details
Debt Financing 2020 $6.4M Details
Debt Financing 2020 $6.4M Details
Debt Financing 2020 $6.4M Details